Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
18
Synta Pharmaceuticals Corp, a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
After four years of research, a new test will help identify cancer in women with ovarian cysts before surgery. Until the OVA1 blood test was created, a precise diagnosis before surgery wasn't possible, said Dr. Frederick R. Ueland, associate professor of gynecologic oncology at the University of Kentucky College of Medicine and a principal investigator on the research project.
After losing her mother to cancer, Shelia Weeks, 61, was advised by her doctor to begin receiving mammograms when she was 36. Her mother's cancer was found in her liver, but started in her breast. There was no widespread detection method such as mammograms at that time. She passed away in 1982.
A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America(R) (CTCA) in Philadelphia. CTCA will become the first in the country to offer this treatment option using the Novac7 technology from Rome, Italy.
17
Joe Bacal survived Hodgkin's lymphoma and now he takes on the Baja 1000 - a 675-mile off-road race through the Mexican desert. Bacal hopes to inspire other cancer patients to take control of their cancer care.
HistoRx today announced that the Company's proprietary AQUA technology, an automated image analysis platform based on tissue-based quantitative immunofluorescence, was noted in a recent National Comprehensive Cancer Network (NCCN) Task Force Report on hormone receptor testing in breast cancer as one of the promising new strategies being developed for the measurement of ER and PgR in breast cancer tissue.
16
U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths.
When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information.
OSI Pharmaceuticals, Inc. announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R) (erlotinib) as a first-line maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum- based chemotherapy at its December 16, 2009 meeting.
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux(R) (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
We care about your feedback. Let us know how we can improve your CancerCompass experience.